STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012

Global Alliance to Immunize Against AIDS Vaccine Foundation

Status: Completed

Conditions: HPV; HPV-Related Cervical Carcinoma

Treatments: Behavioral: HPV Vaccine Acceptance Survey

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT05767138

HPV Vaccine Survey

Details and patient eligibility

About

Although screening for pre-cancerous cervical lesions and human papilloma virus (HPV) vaccination are accepted and effective means to prevent cervical cancer, women in Mali have limited access to these interventions. In addition, cervical cancer prevention by HPV vaccination has been controversial in some settings. To reduce cervical cancer prevalence and increase HPV vaccine uptake, it is important to understand the level of knowledge about cervical cancer screening and practices related to vaccination in at-risk populations. In this study, the level of knowledge about HPV and cervical cancer and attitudes towards vaccination were assessed among 301 participants (male and female, adults and adolescents) in a house-to-house survey in two urban neighborhoods in Bamako, Mali. The survey was combined with a brief educational session on HPV. Prior to the education session, overall knowledge of HPV infection and cervical cancer was very low: only 8% knew that HPV is a sexually transmitted infection (STI). Less than 20% of women had ever consulted a gynecologist and less than 3% had ever had cervical cancer screening. After hearing a description of HPV vaccine, more than 80% would accept HPV vaccination; fathers and husbands were identified as primary decisions makers and local clinics or the home as preferred sites for vaccination. This study provides information on STI knowledge and vaccine acceptance in Bamako, Mali in 2012, prior to the introduction of HPV vaccination.

Enrollment: 301 patients

Sex: All

Ages: 12+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 12-17 years of age, with guardian consent
• 18 years or older
• Male or Female
• Living in Mèkin-Sikoro and Djikoroni

Exclusion criteria

• 12-17 years of age, without guardian consent
• <12 years of age
• Living outside Mèkin-Sikoro and Djikoroni

Trial design

301 participants in 1 patient group

Bamako Participants

Description:

301 male and female participants. Teenagers and adults. Living in two urban regions of Bamako.

Treatment:

Behavioral: HPV Vaccine Acceptance Survey